Thiogenesis Therapeutics, Corp.
TTIPF
$0.44
$0.02897.03%
OTC PK
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 4.06% | -8.03% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.07% | -15.52% | |||
| Operating Income | 7.07% | 15.52% | |||
| Income Before Tax | -1.18% | 9.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.18% | 9.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.18% | 9.68% | |||
| EBIT | 7.07% | 15.52% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -0.95% | 11.02% | |||
| Normalized Basic EPS | -1.54% | 12.16% | |||
| EPS Diluted | -0.95% | 11.02% | |||
| Normalized Diluted EPS | -1.54% | 12.16% | |||
| Average Basic Shares Outstanding | 0.01% | 1.81% | |||
| Average Diluted Shares Outstanding | 0.01% | 1.81% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||